Pathology and Molecular Diagnostics
A section of Diagnostics (ISSN 2075-4418).
Section Information
This section of Diagnostics aims to enable the rapid publication of contributions regarding medical diagnostic tests, particular biopsy, blood and other biofluids analysis, and on the use of biomarkers or genetic test methods to diagnose and monitor disease. Topics include, but are not limited to:
- pathology, including cytopathology, hematopathology, histopathology, etc.
- biopsy
- immunoassays
- molecular diagnostics
- liquid biopsy
- assays
- biomarkers
- medical screening
- genetic testing
- prenatal diagnosis
- precision and personalized medicine
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Diagnostics in Neuromuscular Disorders (Deadline: 31 May 2022)
- Diagnosis and Assessment of Spondyloarthritis (Deadline: 31 May 2022)
- Utilization of Liquid Biopsy in Cancer Diagnosis and Management (Deadline: 31 May 2022)
- Advance in the Diagnostics of Ovarian Neoplasms (Deadline: 31 May 2022)
- Challenges and Advances in Inflammation Related Diagnostics (Deadline: 31 May 2022)
- Myelodysplastic Syndrome: Diagnosis and Screening (Deadline: 31 May 2022)
- Appendicitis: Diagnosis and Management (Deadline: 31 May 2022)
- Advances in Anatomy (Deadline: 31 May 2022)
- Clinical and Pathological Approach of Head and Neck Tumor (Deadline: 31 May 2022)
- Epigenetics in Diagnosis and Treatment of Cancer (Deadline: 31 May 2022)
- Digital Pathology: Records of Successful Implementations (Deadline: 31 May 2022)
- Advances in Pulmonary Embolism Diagnosis (Deadline: 31 May 2022)
- The Application of Next Generation Sequencing for the Diagnosis and Treatment of Patients in Emergency and Critical Care Setting (Deadline: 31 May 2022)
- Novel Advances in Diagnostic Work-Up of Respiratory Diseases (Deadline: 31 May 2022)
- Diagnosis of Rheumatoid Arthritis (Deadline: 31 May 2022)
- Advances in Retinopathy (Deadline: 31 May 2022)
- Advances in the Diagnosis of Lung Nodules (Deadline: 31 May 2022)
- Diagnosis and Management for Obstetric and Gynecologic Diseases 2.0 (Deadline: 31 May 2022)
- Diagnosis and Management of Sleep Disorders (Deadline: 31 May 2022)
- Innovations in Laboratory Hematology and Flow Cytometry (Deadline: 1 June 2022)
- Recent Advances in Liver Diseases Diagnosis (Deadline: 1 June 2022)
- Cell-Free Nucleic Acids—New Insights into Physico-Chemical Properties, Analytical Considerations, and Clinical Applications (Deadline: 10 June 2022)
- Advances in Diagnostics of Otology and Neurotology (Deadline: 30 June 2022)
- Fecal Immunochemical Test: Colorectal Cancer Screening and Beyond (Deadline: 30 June 2022)
- Diagnosis and Management of Thrombosis in COVID-19 (Deadline: 30 June 2022)
- Diagnosis and Management in Prenatal Medicine (Deadline: 30 June 2022)
- Immune-Related Adverse Events Diagnosis and Immunotherapy in Cancer (Deadline: 30 June 2022)
- Animal Models in Human Diagnostics (Deadline: 30 June 2022)
- Metabolic Diseases: New Perspectives in Diagnosis, Tools and Treatment (Deadline: 30 June 2022)
- Diagnosis of Polycystic Ovary Syndrome (PCOS): State-of-the-Art and Open Questions (Deadline: 30 June 2022)
- Hepatobiliary Diseases: Diagnosis and Management (Deadline: 30 June 2022)
- Evidence-Based Diagnosis and Management of Facial Nerve Disorders (Deadline: 30 June 2022)
- Advances in the Diagnostics of Endometriosis (Deadline: 30 June 2022)
- New Progress in Diagnostics of Clinical Hypertension (Deadline: 30 June 2022)
- Non-alcoholic Fatty Liver Disease: Diagnosis and Management (Deadline: 30 June 2022)
- Smart Drugs and Anabolic-Androgenic Steroids: Searching Innovative Applications and New Molecular Biomarkers (Deadline: 30 June 2022)
- Diagnostic Challenges of Malignant Pleural Mesothelioma (Deadline: 30 June 2022)
- The Role of Immunohistochemistry in the Diagnosis and Prognosis of Tumors: New Findings (Deadline: 30 June 2022)
- Biomarkers of Urological Disease (Deadline: 30 June 2022)
- Advance in the Diagnostics and Management of Musculoskeletal Diseases (Deadline: 30 June 2022)
- Diagnosis of Spinal Tumors (Deadline: 30 June 2022)
- Advances in the Diagnosis and Management of Rheumatic Diseases (Deadline: 30 June 2022)
- RNA in Cancer Diagnostics: From Basic to Translational Application (Deadline: 30 June 2022)
- Diagnosis and Management of Alzheimer's Disease (Deadline: 30 June 2022)
- Multimodal Imaging and Biomarkers in Diagnosis of Heart Failure (Deadline: 30 June 2022)
- Chronic Subdural Hematoma (Deadline: 30 June 2022)
- Advances in the Diagnosis of Interstitial Lung Diseases (Deadline: 30 June 2022)
- Advances in the Diagnosis of Gastrointestinal Diseases (Deadline: 30 June 2022)
- Advanced Neuroimaging in Fetal, Neonatal, Infant and Child Health (Deadline: 1 July 2022)
- Cervical Cancer Screening, Management, and Prevention (Deadline: 1 July 2022)
- Advancements on Diagnostic and Management of Liver Disease (Deadline: 10 July 2022)
- Diagnosis of Lower Genital Tract Disease (Deadline: 31 July 2022)
- Recent Advances in the Diagnosis of Metabolic Disorders (Deadline: 31 July 2022)
- Current Diagnostic Concepts of Eye Pathology (Deadline: 31 July 2022)
- Current and Future Approaches to Prevention and Early Detection of Women's Cancers (Deadline: 31 July 2022)
- Diagnosis and New Insights in Primary Ciliary Dyskinesia (Deadline: 31 July 2022)
- Advances in Prenatal Diagnostics (Deadline: 31 July 2022)
- Advances in Breast Biopsy (Deadline: 31 July 2022)
- Diagnosis and Management of Dementia (Deadline: 31 July 2022)
- Structure-Function Relationship in Retinal Diseases (Deadline: 31 July 2022)
- Diagnostic Advances in Cardiovascular Prevention (Deadline: 31 July 2022)
- Immunohistochemistry in Cancer Diagnoses and Treatments (Deadline: 31 July 2022)
- Predictive and Prognostic Markers in Critically Ill Patients (Deadline: 31 July 2022)
- Diagnosis and Management of Gynecological Cancers (Deadline: 31 July 2022)
- Refining Diagnosis in Ophthalmology through Laboratory Research (Deadline: 31 July 2022)
- Pediatric Liver Diseases (Deadline: 31 July 2022)
- State-of-the-Art Research on Endometrial Cancer (Deadline: 31 July 2022)
- Diagnostic and Management of Acquired Hemophilia (Deadline: 31 July 2022)
- Mucopolysaccharidoses: Diagnosis, Treatment, and Management, Volume 3 (Deadline: 31 July 2022)
- Diagnosis and Management in Trauma Surgery (Deadline: 31 July 2022)
- Advances in Diagnostics of Skin Diseases (Deadline: 31 July 2022)
- Clinicopathology and Prognosis of Hepatocellular Carcinoma (Deadline: 31 July 2022)
- Knee Osteoarthritis: Current Challenges in Diagnosis and Management (Deadline: 31 July 2022)
- Sinonasal Disorders: Biomarkers for Diagnosis and Prognosis (Deadline: 31 August 2022)
- Circulating Factors—CAMLs, CTC/cfDNA/mRNA—Predictive Factors to Aide in Diagnoses and Recurrence of Cancer (Deadline: 31 August 2022)
- Eye Diseases: Diagnosis and Management (Deadline: 31 August 2022)
- Renal Cell Carcinoma: From Diagnosis to Identification of Novel Therapeutic Targets and Minimally Invasive Treatments (Deadline: 31 August 2022)
- Diagnosis and Management of Multiple Sclerosis (Deadline: 31 August 2022)
- Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (Deadline: 31 August 2022)
- Biomarkers in Diagnosis and Management of Hepatocellular Carcinoma (Deadline: 31 August 2022)
- Clinical Advances in Heart Failure (Deadline: 31 August 2022)
- Prognostic Factors for Pediatric Tumors (Deadline: 31 August 2022)
- Advances in Diagnostic Cytopathology (Deadline: 31 August 2022)
- Diagnostics and Management of Tuberculosis and COVID-19 Co-Infection (Deadline: 31 August 2022)
- Prediction and Diagnosis of Sepsis (Deadline: 31 August 2022)
- Advances in the Diagnosis and Management of ENT Diseases (Deadline: 31 August 2022)
- Early Diagnosis of Mood Disorders: Focus on Bipolar Disorder and Major Depression (Deadline: 31 August 2022)
- Vitamin D as a Biomarker in the Standardization Era: A Clinical Point of View (Deadline: 31 August 2022)
- New Insights in Thyroid Diagnostics 2.0 (Deadline: 31 August 2022)
- Gastric Cancer: Diagnosis and Management (Deadline: 31 August 2022)
- Advances in the Diagnosis and Management of Otopharyngeal Diseases (Deadline: 31 August 2022)
- Advances in Lymphoma Molecular Diagnostics (Deadline: 31 August 2022)
- Classification, Clinicopathological Features, and Prognosis of Thymomas (Deadline: 31 August 2022)
- Advancements in Morphological and Molecular Prenatal Diagnosis: European Practice and Future Perspectives (Deadline: 31 August 2022)
- The Rise of Diagnostics in the Treatment of Chronic Wounds 2.0 (Deadline: 31 August 2022)
- Advances in the Detection and Screening of Gastric Cancer (Deadline: 31 August 2022)
- Trauma Diagnosis: Multidisciplinary Management and Forensic Profiles (Deadline: 31 August 2022)
- Advances in the Diagnosis and Management of Psychosis (Deadline: 31 August 2022)
- Salivary Gland Disorders: Diagnosis, Prognosis, and Treatment (Deadline: 31 August 2022)
- Endoscopy and Diagnostic Tools in Hepatobiliary and Pancreatic Diseases (Deadline: 31 August 2022)
- New Entities, New Approaches of Endocrine Diseases (Deadline: 31 August 2022)
- Detection, Diagnosis, and Management of Bladder Cancer—Integration of Non-invasive Diagnostics into Medical Decision Making (Deadline: 31 August 2022)
- Biomarkers for Detection and Prognosis in Urologic Oncology (Deadline: 31 August 2022)
- Diagnosis and Factors Associated with Perinatal Health (Deadline: 15 September 2022)
- The Diagnostic and Therapeutic Value of RNAs in Human Diseases (Deadline: 15 September 2022)
- Novel Approaches in the Diagnosis of Primary and Secondary Disease within Colorectal Cancer (Deadline: 15 September 2022)
- Early Prenatal Diagnosis of Fetal Aneuploidies and Other Genetic Conditions (Deadline: 15 September 2022)
- Precision Medicine in Autoimmunity (Deadline: 20 September 2022)
- Advances in Identification and Management of Systemic Sclerosis (Deadline: 30 September 2022)
- Tissue-Based Biomarkers of Solid Tumors in the Routine Clinical Setting 2.0 (Deadline: 30 September 2022)
- Thoracic Aortic Disease: From Bench to Bedside (Deadline: 30 September 2022)
- Epigenetic Biomarkers and Diagnostics (Deadline: 30 September 2022)
- Tissue Spatially Resolved Molecular Profiling for Personalized Oncology (Deadline: 30 September 2022)
- Recent Studies of Cardiomyopathy Diagnosis (Deadline: 30 September 2022)
- Advances in Pediatric Neuro-Oncology 2.0 (Deadline: 30 September 2022)
- Advances in Interventional Pulmonology (Deadline: 30 September 2022)
- Chronic Fatigue-Spectrum Disorders in the Era of COVID-19 (Deadline: 30 September 2022)
- Biomarkers of Sepsis (Deadline: 30 September 2022)
- State of the Art of Bladder Cancer: From Diagnosis to Therapy (Deadline: 30 September 2022)
- Novel Biomarkers in Leukemia: From Benchtop to Bedside (Deadline: 30 September 2022)
- Kidney Disease: Biomarkers, Diagnosis and Prognosis (Deadline: 30 September 2022)
- Diagnosis and Management of Diseases in Fragile and Elderly Patients (Deadline: 30 September 2022)
- Prognostic Role of White Blood Cells and Platelets Count Changes in Solid Tumors (Deadline: 30 September 2022)
- Advances in the Diagnostics of Osteoarthritis (Deadline: 30 September 2022)
- Chronic Pain and Fibromyalgia: Biomarkers and Pathophysiology (Deadline: 30 September 2022)
- Diagnostic Pathology of Lymphomas and Lymphoproliferative Disorders (Deadline: 5 October 2022)
- Liquid Biopsy and Precision Oncology (Deadline: 15 October 2022)
- Recent Advances in Diagnosis of Malignant Mesothelioma (Deadline: 20 October 2022)
- Clinical Characteristics of Headache and Diagnosis of Primary and Secondary Headache Disorders (Deadline: 20 October 2022)
- Advances in Cerebrospinal Fluid Diagnostics (Deadline: 20 October 2022)
- Diagnosis and Management of Congenital Heart Disease (Deadline: 28 October 2022)
- Diagnosis for Hematologic Disorders (Deadline: 28 October 2022)
- Breast Cancer Metastasis, Diagnostic and Therapeutic Approaches 2022 (Deadline: 30 October 2022)
- T-cells as a Diagnostic Tool in Benign and Malignant Disease (Deadline: 31 October 2022)
- Emerging Biomarkers for Immune Checkpoint Inhibitors in Tumors (Deadline: 31 October 2022)
- Risk Factors and Biomarkers for Cardiovascular Disease (Deadline: 31 October 2022)
- Biomarkers in Psychiatry (Deadline: 31 October 2022)
- Advances in Glycogen Storage Disease (Deadline: 31 October 2022)
- Predictive and Prognostic Biomarkers of Human Cancer in Italy (Deadline: 31 October 2022)
- Clinical Prognostic and Predictive Biomarkers (Deadline: 31 October 2022)
- Molecular Diagnosis of Interstitial Lung Disease (Deadline: 31 October 2022)
- Neuropathic Pain: Correct Diagnosis for Correct Management 2.0 (Deadline: 31 October 2022)
- Diagnosis and Treatment of Periodontal Diseases in 2022 (Deadline: 31 October 2022)
- 2022 Padua Days on Muscle and Mobility Medicine – On-Site (Deadline: 10 November 2022)
- Coronavirus and Brain: Diagnosing and Treating COVID-19’s Neurological Effects (Deadline: 18 November 2022)
- Clinical Diagnostics, Biomarkers and Pathology in Parkinson's Disease (Deadline: 18 November 2022)
- Acute Myocardial Infarction: Diagnosis and Management (Deadline: 25 November 2022)
- Advance in Emerging Transcriptome Sequencing Technologies (Deadline: 30 November 2022)
- Diagnosis and Management of Liver Diseases (Deadline: 30 November 2022)
- Genetic Diagnosis of Pediatric Diseases (Deadline: 30 November 2022)
- Cervical Cancer & Cervical Dysplasia: Screening, Diagnosis, and Treatment (Deadline: 30 November 2022)
- Advances in the Diagnosis and Management of Autoimmune Pediatric Diseases (Deadline: 30 November 2022)
- Diagnosis and Treatment of Craniofacial and Oral Disease (Deadline: 30 November 2022)
- Advances in the Diagnosis of Nervous System Diseases (Deadline: 30 November 2022)
- Advances in the Pathology of Lung, Brain, and Heart Diseases (Deadline: 30 November 2022)
- Diagnosis of Neonatal Diseases (Deadline: 30 November 2022)
- Pathology and Diagnosis of Gynecologic Diseases (Deadline: 30 November 2022)
- Multidisciplinary Approach in Metastatic Cancer Patients (Deadline: 30 November 2022)
- Advances in the Diagnosis and Management of Tumors/Cancers (Deadline: 30 November 2022)
- Diagnosis of Mucopolysaccharidoses and Mucolipidoses (Deadline: 30 November 2022)
- Diagnosis and Treatment of Shoulder and Elbow Disease and Trauma 2.0 (Deadline: 30 November 2022)
- Cardio-Renal Metabolic Syndrome: Interdisciplinary Diagnostic Methods 2.0 (Deadline: 30 November 2022)
- Prenatal Diagnosis: Current Trends and Future Directions (Deadline: 15 December 2022)
- Advances in Diagnostics of Head and Neck Cancer: Volume II (Deadline: 16 December 2022)
- Pediatric Cholestatic Liver Disorders (Deadline: 20 December 2022)
- Monitoring and Diagnosis of Patients during Rehabilitation Training (Deadline: 20 December 2022)
- New Assays in the Diagnosis of Coagulation Protein Disorders (Deadline: 31 December 2022)
- Current Concepts and Prospects of Diagnostics in Oral Diseases (Deadline: 31 December 2022)
- Diagnosis of Adverse Reactions to Drugs (Deadline: 31 December 2022)
- Recent Advances in Thyroid Carcinoma (Deadline: 31 December 2022)
- Urinary Biomarkers and Disease Diagnosis (Deadline: 31 December 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
